Olivia Munn—who shared her breast cancer diagnosis last March—praised Kate Middleton for speaking about her cancer journey ...
After surviving three types of cancer and having to face the harsh realities of colorectal and endometrial cancer and basal ...
After surviving three types of cancer and having to face the harsh realities of colorectal and endometrial cancer and basal cell carcinoma, I know just how crucial early detection can be in saving ...
WVNS Bluefield on MSN
Stories of Strength: June Hendry’s Battle on Two Fronts
For some people, their breast cancer diagnosis and date of remission are far removed. They still feel the toll their journey ...
MSD, known as Merck & Co in the US and Canada, licensed rights to Lenvima in 2018 in a near-$6 billion deal aimed at developing it as a partner drug to Keytruda. The combination has been approved for ...
Against all medical advice, Mwende Mutiso carried her healthy baby to term, choosing motherhood over immediate, aggressive cancer treatment. Now, as her cancer returns, she has no regrets ...
NUTLEY, N.J., Nov. 3, 2025 /PRNewswire/ -- Eisai announced today the presentation of clinical research in gynecologic oncology during the International Gynecologic Cancer Society (IGCS) 2025 Annual ...
Talking With Docs on MSN
Important endometrial cancer information
Epstein Survivor's Family Declares 'Victory' After Prince Andrew Is Stripped Of Royal Title Scientists Studied 'SuperAgers' ...
At five years, KEYTRUDA plus LENVIMA showed a 16.7% overall survival (OS) rate for these patients with mismatch repair proficient (pMMR) advanced endometrial carcinoma versus 7.3% for chemotherapy ...
The ultimate recommendation is to utilize immune checkpoint blockade in the front-line setting, even for pMMR patients. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback